NYSE · SIHealthcareSurgical Instruments

Shoulder Innovations financials

$18.79+4.68%
Close Sep 29, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

Fiscal yearFY25
Dec 31
Revenue$47.3M
Gross profit$36.2M
Gross margin76.5%
Operating income-$26.3M
Net income-$40.4M
Net margin−85.3%
Diluted EPS$-4.65
EBITDA-$23.1M
Operating cash flow-$28.6M
Free cash flow-$36.0M
Diluted shares8.7M

Balance sheet

Period endDec 31
Cash & equivalents$26.9M
Short-term investments$97.4M
Total debt$14.9M
Total assets$169.9M
Total liabilities$29.2M
Shareholders' equity$140.8M

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology